459 related articles for article (PubMed ID: 30903869)
1. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
[TBL] [Abstract][Full Text] [Related]
2. Cytokines and Effector/Regulatory Cells Characterization in the Physiopathology of Cutaneous Lupus Erythematous: A Cross-Sectional Study.
Méndez-Flores S; Hernández-Molina G; Enríquez AB; Faz-Muñoz D; Esquivel Y; Pacheco-Molina C; Furuzawa-Carballeda J
Mediators Inflamm; 2016; 2016():7074829. PubMed ID: 27041826
[TBL] [Abstract][Full Text] [Related]
3. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
4. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
[TBL] [Abstract][Full Text] [Related]
5. Skin CD4
Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
[TBL] [Abstract][Full Text] [Related]
6. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
Hu FQ; Zhang YP; Yin J; Tang ZQ; Han YF; Shi ZR; Tan GZ; Wang L
Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Expression in Cutaneous Lupus: A New Window to Understand Its Pathogenesis.
Méndez-Flores S; Furuzawa-Carballeda J; Hernández-Molina G; Ramírez-Martinez G; Regino-Zamarripa NE; Ortiz-Quintero B; Jiménez-Alvarez L; Cruz-Lagunas A; Zúñiga J
Mediators Inflamm; 2019; 2019():5049245. PubMed ID: 32082077
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
9. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
[TBL] [Abstract][Full Text] [Related]
10. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
11. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
13. BAFFR expression in circulating T follicular helper (CD4
Sagrero-Fabela N; Ortíz-Lazareno PC; Salazar-Camarena DC; Cruz A; Cerpa-Cruz S; Muñoz-Valle JF; Marín-Rosales M; Alvarez-Gómez JA; Palafox-Sánchez CA
Lupus; 2023 Aug; 32(9):1093-1104. PubMed ID: 37460408
[TBL] [Abstract][Full Text] [Related]
14. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
Braunstein I; Klein R; Okawa J; Werth VP
Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
[TBL] [Abstract][Full Text] [Related]
15. Increased CD4
Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L
Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752
[TBL] [Abstract][Full Text] [Related]
16. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
17. The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.
Caproni M; Torchia D; Antiga E; Giomi B; Mercuri M; Volpi W; Fabbri P
J Rheumatol; 2007 Dec; 34(12):2412-6. PubMed ID: 18050371
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
[TBL] [Abstract][Full Text] [Related]
19. Mast cells in systemic and cutaneous lupus erythematosus.
Kaczmarczyk-Sekuła K; Dyduch G; Kostański M; Wielowieyska-Szybińska D; Szpor J; Białas M; Okoń K
Pol J Pathol; 2015 Dec; 66(4):397-402. PubMed ID: 27003772
[TBL] [Abstract][Full Text] [Related]
20. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.
Magro CM; Segal JP; Crowson AN; Chadwick P
J Cutan Pathol; 2010 Jun; 37(6):659-71. PubMed ID: 19891658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
